Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
Leukemia & Lymphoma
|
August 27, 2020
Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population
Paola Ghione, Shunan Qi, Brandon S Imber, et al.
The Oncologist
|
July 10, 2025
Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case series
Ian Nykaza, Andrea Moy, Stephen W Dusza, et al.
Haematologica
|
March 19, 2026
Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets
Robert Stuver, Haiming Tang, Ahmet Dogan, et al.
Journal of the American Academy of Dermatology
|
February 1, 2019
Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin
Meenal K Kheterpal, Julia Dai, Shamir Geller, et al.
Leukemia & Lymphoma
|
August 16, 2022
Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design
Anita Kumar, Carla Casulo, Erel Joffe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 2016
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma
Heiko Schöder, Andrew D Zelenetz, Paul Hamlin, et al.
Haematologica
|
November 27, 2025
Cumulative incidence and factors associated with subsequent myeloid neoplasms in patients with nodal T-follicular helper cell lymphomas
Kai Shiang Lin, Mingfei Yan, Nivetha Ganesan, et al.
Blood Neoplasia
|
June 24, 2025
CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas
Paola Ghione, Kurt S Bantilan, Erel Joffe, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 7, 2020
Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma
Pierluigi Porcu, Stacie Hudgens, Steven Horwitz, et al.
Cancer Immunology Research
|
June 14, 2018
Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile
Christiane Querfeld, Samantha Leung, Patricia L Myskowski, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
Leukemia & Lymphoma
|
August 27, 2020
Modified SMILE (mSMILE) and intensity-modulated radiotherapy (IMRT) for extranodal NK-T lymphoma nasal type in a single-center population
Paola Ghione, Shunan Qi, Brandon S Imber, et al.
The Oncologist
|
July 10, 2025
Immuno-oncologyDupilumab for bullous pemphigoid related to immune checkpoint inhibitors: a retrospective case series
Ian Nykaza, Andrea Moy, Stephen W Dusza, et al.
Haematologica
|
March 19, 2026
Non-JAK-family gene fusions in cutaneous T-cell lymphoma highlights genetic diversity and potential therapeutic targets
Robert Stuver, Haiming Tang, Ahmet Dogan, et al.
Journal of the American Academy of Dermatology
|
February 1, 2019
Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin
Meenal K Kheterpal, Julia Dai, Shamir Geller, et al.
Leukemia & Lymphoma
|
August 16, 2022
Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design
Anita Kumar, Carla Casulo, Erel Joffe, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 1, 2016
Prospective Study of 3'-Deoxy-3'-18F-Fluorothymidine PET for Early Interim Response Assessment in Advanced-Stage B-Cell Lymphoma
Heiko Schöder, Andrew D Zelenetz, Paul Hamlin, et al.
Haematologica
|
November 27, 2025
Cumulative incidence and factors associated with subsequent myeloid neoplasms in patients with nodal T-follicular helper cell lymphomas
Kai Shiang Lin, Mingfei Yan, Nivetha Ganesan, et al.
Blood Neoplasia
|
June 24, 2025
CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas
Paola Ghione, Kurt S Bantilan, Erel Joffe, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 7, 2020
Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma
Pierluigi Porcu, Stacie Hudgens, Steven Horwitz, et al.
Cancer Immunology Research
|
June 14, 2018
Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile
Christiane Querfeld, Samantha Leung, Patricia L Myskowski, et al.
Page
of 7